Seth Reno
President and CEO at Arkayli Biopharma, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Arkayli Biopharma, Inc.
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
President and CEO
-
Feb 2022 - Present
Madison, WI United States Our mission is to develop novel medications with precision drug delivery systems to enhance efficacy and maximize safety of treatments for children and adults with vascular anomalies. Our lead product candidate, ARK001, has the potential to be the first FDA-approved non-systemic topical (applied to the skin) treatment for infantile hemangioma (IH).
-
-
-
-
Principal
-
Oct 2019 - Present
A strategic healthcare advisor helping life science companies at all stages of development with commercial strategy, business development and operational efficiency.
-
-
-
NeuroBo Pharmaceuticals, Inc.
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Commercial Advisor
-
Jan 2020 - Jan 2022
Boston, Massachusetts, United States NeuroBo is a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases.
-
-
-
Gemphire Therapeutics
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Chief Commercial Officer
-
Aug 2015 - Dec 2019
Northville, MI Led strategic market planning, business development, competitive intelligence and formation of strategic partnerships. Merged with NeuroBo Pharmaceuticals 12/2019
-
-
-
AstraZeneca
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Commercial Insights/New Product Planning
-
Jan 2015 - Apr 2015
• Lead a specialized team of 4 direct reports (senior directors), 10 total staff, in support of new product planning. • Provide insights on commercial assets in preparation for product launches in respiratory, autoimmune, and infectious disease (ID), focusing on “go to market” strategies for biologics: o Cold chain distribution for Caprelsa®, Faslodex®, and Lynparza®, including specialty pharmacy HUB distribution and access services. o ID: Sizing and structure for Synagis® and… Show more • Lead a specialized team of 4 direct reports (senior directors), 10 total staff, in support of new product planning. • Provide insights on commercial assets in preparation for product launches in respiratory, autoimmune, and infectious disease (ID), focusing on “go to market” strategies for biologics: o Cold chain distribution for Caprelsa®, Faslodex®, and Lynparza®, including specialty pharmacy HUB distribution and access services. o ID: Sizing and structure for Synagis® and FluMist® Quadrivalent and strategic support for healthcare professionals, distribution, patient access services, and channel assessment. NOTE: AstraZeneca purchased MedImmune in 2007, though commenced full assimilation in 2014. Show less
-
-
-
MedImmune
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Head of Commercial Operations
-
Jul 2013 - Dec 2014
• Led a team of 10 direct reports (directors / senior directors), 75 total staff, with a mandate to thoroughly integrate the MedImmune and AZ commercial teams following AZ’s acquisition of MedImmune. • Facilitated shift of MedImmune’s focus from primary care to specialty care, including “upskilling” capabilities at MedImmune’s Gaithersburg, MD, site to enhance the ability to commercialize multiple biologics. • Managed commercial sales support for the launches of Myalept® and… Show more • Led a team of 10 direct reports (directors / senior directors), 75 total staff, with a mandate to thoroughly integrate the MedImmune and AZ commercial teams following AZ’s acquisition of MedImmune. • Facilitated shift of MedImmune’s focus from primary care to specialty care, including “upskilling” capabilities at MedImmune’s Gaithersburg, MD, site to enhance the ability to commercialize multiple biologics. • Managed commercial sales support for the launches of Myalept® and Lynparza®, as well as submission of several new drug applications (NDA) and biologics applications (BLA); Myalept® was approved and launched within a dramatically short period of 4 months.
-
-
Senior Director, Commercial Insights
-
Jun 2010 - Jul 2013
Gaithersburg, MD • Led a team of 9 direct reports (directors / senior directors), 24 staff total, supporting MedImmune sales and market operations, providing research, forecasting, sales force effectiveness, and analytics across in-line and emerging brands. • Mandated with providing commercial viability to launch a new drug and created a “New Product Planning” team to provide insights for product launches across a diverse therapeutic portfolio, including oncology (ONC), respiratory and autoimmune… Show more • Led a team of 9 direct reports (directors / senior directors), 24 staff total, supporting MedImmune sales and market operations, providing research, forecasting, sales force effectiveness, and analytics across in-line and emerging brands. • Mandated with providing commercial viability to launch a new drug and created a “New Product Planning” team to provide insights for product launches across a diverse therapeutic portfolio, including oncology (ONC), respiratory and autoimmune (RIA), cardiovascular, metabolic , and infectious disease. • Determined global pricing and market access (GPMA).
-
-
-
AstraZeneca
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Brand Insight Director, Dyslipidemia Franchise
-
Dec 2007 - Jun 2010
Wilmington Delaware • Led a high performance brand insight of 9 direct reports in support of Crestor® across all healthcare provider (HCP), consumer, managed markets and finance teams. • Optimized brand resources to position Crestor® as the fastest growing statin amongst cardiologists and the only branded statin to grow market share over a designated 26-month period. • Led “Designed for Launch” efforts to fully commercialize Certriad®, jointly developed by AZ and Abbot Labs. ★ Award:… Show more • Led a high performance brand insight of 9 direct reports in support of Crestor® across all healthcare provider (HCP), consumer, managed markets and finance teams. • Optimized brand resources to position Crestor® as the fastest growing statin amongst cardiologists and the only branded statin to grow market share over a designated 26-month period. • Led “Designed for Launch” efforts to fully commercialize Certriad®, jointly developed by AZ and Abbot Labs. ★ Award: “2008 Brand Marketing Team of Year” for Crestor® by Medical Marketing Magazine.
-
-
Leader, Commercial Analytics– Field Support (East)
-
Jun 2006 - Dec 2007
• Led a new team of 9 analysts to develop business solutions for MM and sales to be utilized at the business center level (business centers are full vertical business units placed in geographically strategic locations). • Built a national managed markets (MM) analyst and regional business analyst (RBA) team. • Appointed to AZSM1.07 steering committee for MM lead, tasked with developing tools for the new selling model supported by Cornerstone, an internal business unit specializing… Show more • Led a new team of 9 analysts to develop business solutions for MM and sales to be utilized at the business center level (business centers are full vertical business units placed in geographically strategic locations). • Built a national managed markets (MM) analyst and regional business analyst (RBA) team. • Appointed to AZSM1.07 steering committee for MM lead, tasked with developing tools for the new selling model supported by Cornerstone, an internal business unit specializing in managing pharmaceuticals in late life cycle. • Successfully partnered with brand teams to support pharmacy benefit manager (PBM) contracting strategies.
-
-
Leader, Commercial Operations – Field Support (National)
-
Jan 2005 - May 2006
• Led a national team of 11 direct reports (managed markets business analysts) in a customer-facing role covering 8 business centers. • Provided business solutions focusing on MM contracting, proactive analysis, and sales tools to a wide array of internal teams: group purchasing organizations and long term care (GPO & LTC), federal, trade, health plan, pharmacy benefit manager (PBM) and regional account director (RAD) teams. • Implemented Crestor® “Big Three PBM”… Show more • Led a national team of 11 direct reports (managed markets business analysts) in a customer-facing role covering 8 business centers. • Provided business solutions focusing on MM contracting, proactive analysis, and sales tools to a wide array of internal teams: group purchasing organizations and long term care (GPO & LTC), federal, trade, health plan, pharmacy benefit manager (PBM) and regional account director (RAD) teams. • Implemented Crestor® “Big Three PBM” strategy. ★ Award: Circle of Excellence, AZ’s highest sales award, for implementation of the Brand Opprortunity tool set.
-
-
District Sales Manager – CV/Respiratory
-
Mar 2004 - Dec 2004
• As a rotational DSM, successfully lead a CV/Respiratory sales team of 9 pharmacy sales specialists. • Implemented a compass export tool that led to a 65% increase in Crestor® target delivery scores (TDS) over an 8 month period in addition to a 2.1% national market share growth. • Managed Crestor® budget for 38 representatives and 5 DSMs in Buffalo, NY.
-
-
Managed Markets – Senior MM Analyst
-
Feb 2003 - Mar 2004
• Deployed to Nashville / Tampa business centers to work with the Nexium® brand team as MM lead and undertake numerous initiatives and responsibilities: o Spearheaded BCBS Nexium® pull-through program. o Designed Crestor® sales incentive plans. o Supported 2 account director teams through monthly field visits and conducting quarterly reviews with key customers. o Led analytics training for PSS in residency program – “Territory Planning”. o Established contract service… Show more • Deployed to Nashville / Tampa business centers to work with the Nexium® brand team as MM lead and undertake numerous initiatives and responsibilities: o Spearheaded BCBS Nexium® pull-through program. o Designed Crestor® sales incentive plans. o Supported 2 account director teams through monthly field visits and conducting quarterly reviews with key customers. o Led analytics training for PSS in residency program – “Territory Planning”. o Established contract service terms for IMS, the world’s largest vendor of pharmaceutical data. o Managed 3 core national projects. ★ Awards: 3-time recipient of “Best Practice SVP Awards,” issued by the senior vice president of the business center for demonstrating impact in main areas of responsibility.
-
-
Hospital 1 Pharmaceutical Sales Specialist – Washington, DC Area
-
Apr 2001 - Dec 2003
• Represented CNS and pain and infection (P&I) products to teaching institutions, military accounts, and the VA. • Championed and implemented a customer solutions (CS) marketing program to provide unique marketing and educational pieces tailored to the specific needs of large hospital accounts / health care systems in the Washington D.C. area, including the VA, National Institutes of Health (NIH), and Johns Hopkins. Pieces were input directly into the National Quick List, which made… Show more • Represented CNS and pain and infection (P&I) products to teaching institutions, military accounts, and the VA. • Championed and implemented a customer solutions (CS) marketing program to provide unique marketing and educational pieces tailored to the specific needs of large hospital accounts / health care systems in the Washington D.C. area, including the VA, National Institutes of Health (NIH), and Johns Hopkins. Pieces were input directly into the National Quick List, which made them easily and quickly accessible.
-
-
-
Pfizer
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Sales Specialist- Northern Virginia Area
-
1997 - 2001
• Accounts included hospital systems, VA systems, Government healthcare facilities and research institutions. • Represented Wyeth biologics and vaccines and built relationships across several specialists, including infectious disease, endocrinologists, pediatricians, neonatologists, and pulmonologists, in addition to hospital administrators.
-
-
Territory Representative-North / Central Virginia Territory / Sales Analyst / Market Analyst
-
1990 - 1997
-
-
Education
-
University of Delaware
Bachelor of Science (BS) - Human Resources -
Strayer University
Master of Business Administration (MBA), 4.0